Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In Remembrance of Professor Zelig Eshhar: <i>A Life Committed to CAR-T</i>.

Human gene therapy·2026
Same author

Coupling dead cell recognition to Fcγ receptors augments anticancer immunity.

Nature cancer·2026
Same author

Zoonotic bacterial dynamics in two sympatric urban gull species within anthropized environments.

Environmental pollution (Barking, Essex : 1987)·2026
Same author

Contrasting patterns of plastic ingestion and transport by an opportunistic gull across urban and agricultural landscapes.

Environmental research·2026
Same author

In Remembrance of Professor Zelig Eshhar: <i>A Life Committed to CAR-T</i>.

Human gene therapy·2026
Same author

Marine heatwaves are transforming Western mediterranean marine ecosystems.

Scientific reports·2026

Related Experiment Video

Updated: May 4, 2026

An Efficient and High Yield Method for Isolation of Mouse Dendritic Cell Subsets
09:09

An Efficient and High Yield Method for Isolation of Mouse Dendritic Cell Subsets

Published on: April 18, 2016

14.9K

Dendritic cell immunization induces Nonprotective WT1-specific CTL responses in mouse.

Francisco Ramírez1, Yasmeen Ghani, Liquan Gao

  • 1Department of Immunology and Molecular Pathology, Royal Free and University College Medical School, Rowland Hill Street, London NW3 2PF, UK.

Journal of Immunotherapy (Hagerstown, Md. : 1997)
|May 2, 2007
PubMed
Summary

Tumor antigen Wilms tumor 1 (WT1) epitopes were tested for immunogenicity. Dendritic cell vaccination induced cytotoxic T lymphocyte (CTL) responses, but these lacked anti-tumor activity, suggesting immune tolerance to WT1.

More Related Videos

Development and Functional Characterization of Murine Tolerogenic Dendritic Cells
09:51

Development and Functional Characterization of Murine Tolerogenic Dendritic Cells

Published on: May 18, 2018

10.3K
Chemical Conjugation of a Purified DEC-205-Directed Antibody with Full-Length Protein for Targeting Mouse Dendritic Cells In Vitro and In Vivo
10:35

Chemical Conjugation of a Purified DEC-205-Directed Antibody with Full-Length Protein for Targeting Mouse Dendritic Cells In Vitro and In Vivo

Published on: February 5, 2021

3.0K

Related Experiment Videos

Last Updated: May 4, 2026

An Efficient and High Yield Method for Isolation of Mouse Dendritic Cell Subsets
09:09

An Efficient and High Yield Method for Isolation of Mouse Dendritic Cell Subsets

Published on: April 18, 2016

14.9K
Development and Functional Characterization of Murine Tolerogenic Dendritic Cells
09:51

Development and Functional Characterization of Murine Tolerogenic Dendritic Cells

Published on: May 18, 2018

10.3K
Chemical Conjugation of a Purified DEC-205-Directed Antibody with Full-Length Protein for Targeting Mouse Dendritic Cells In Vitro and In Vivo
10:35

Chemical Conjugation of a Purified DEC-205-Directed Antibody with Full-Length Protein for Targeting Mouse Dendritic Cells In Vitro and In Vivo

Published on: February 5, 2021

3.0K

Area of Science:

  • Immunology
  • Cancer Research
  • Tumor Immunology

Background:

  • Wilms tumor 1 (WT1) is a tumor-associated antigen.
  • Understanding WT1 immunogenicity is crucial for developing cancer immunotherapies.
  • Cytotoxic T lymphocytes (CTLs) are key effectors in anti-tumor immunity.

Purpose of the Study:

  • To evaluate the immunogenicity of two WT1 epitopes (pWT330 and pWT126) in mice.
  • To assess the potential of dendritic cell (DC) vaccination for generating anti-WT1 CTL responses.
  • To determine if DC-induced CTLs against WT1 can mediate anti-tumor effects.

Main Methods:

  • Mice were immunized with WT1 peptides alone or coated onto dendritic cells (DCs).
  • CTL responses were measured by avidity and killing of tumor cell lines.
  • In vivo tumor protection assays were performed using WT1-expressing tumors.
  • Control vaccinations used ovalbumin (OVA) peptides on DCs.

Main Results:

  • Both WT1 epitopes were weakly immunogenic when administered with incomplete Freund adjuvant.
  • DC vaccination readily induced CTL responses against both WT1 epitopes.
  • However, these WT1-specific CTLs exhibited low avidity and failed to recognize or kill WT1-expressing tumor cells in vitro.
  • DC vaccination with WT1 peptides did not confer protection against tumor challenge in vivo.
  • In contrast, DC vaccination with OVA peptides induced protective anti-tumor CTL responses.

Conclusions:

  • DC vaccination can induce CTL responses against self-antigen WT1 epitopes.
  • Tolerance to WT1 likely interferes with the generation of protective anti-tumor CTL immunity.
  • These findings highlight challenges in developing effective immunotherapies targeting WT1.